Ana R. Delgado

Metasíntesis en dos pasos de la investigación temática sobre la regulación emocional en pacientes oncológicos

Jennifer Pérez‐Sánchez, Ana R. Delgado

Objetivo: llevar a cabo una metasíntesis temática (un tipo de metaanálisis cualitativo) sobre las estrategias de regulación emocional empleadas por los pacientes oncológicos. Métodos: en un primer paso, se seleccionaron y analizaron deductivamente treinta y seis temas procedentes de dieciocho análisis temáticos …

es (code pays fourni par la source)

PO:11:297 Kidney function preservation with belimumab in patients with lupus nephritis receiving MMF standard therapy in BLISS-LN: improved proteinuria, clinical outcomes and biomarkers for belimumab vs placebo

Brad H Rovin, Hans‐Joachim Anders, George K Bertsias, Ana R. Delgado et autres

Objectives Belimumab (BEL) is a B-cell modulating anti-BLyS mAb approved for SLE (2011) and LN (2020). BLISS-LN’s unique design (104-week registrational Phase 3 study; NCT01639339) investigating kidney outcomes with BEL allowed ISN/RPS class III or IV ± V or pure class V, …

us, de, gr, ie (code pays fourni par la source)

Evaluation of Long-Term Disease Modification with Belimumab (BEL) in Routine Care of Patients (Pts) with Lupus Nephritis (LN): The OBSErve-LN Study

Keiju Hiromura, Julia Weinmann‐Menke, Enrique Morales, Brad H. Rovin et autres

Background: In LN, the treatment goal of disease modification is indicated by preserved kidney function and end-stage kidney disease prevention >5 years after treatment. BEL was approved for active LN following the 2-year BLISS-LN trial (NCT01639339), which demonstrated significant kidney outcome improvements. …

jp, de, es, us, cn, in, gb (code pays fourni par la source)

Kidney Function Preservation with Belimumab in Patients with Lupus Nephritis Receiving Mycophenolate Mofetil (MMF) Standard Therapy in the BLISS-LN Trial: Improved Proteinuria, Clinical Outcomes, and Biomarkers for Belimumab vs. Placebo

Brad H. Rovin, Hans‐Joachim Anders, George Βertsias, Ana R. Delgado et autres

Background: Belimumab (BEL) is a B-cell modulating anti-BLyS mAb approved for SLE (2011) and LN (2020). BLISS-LN’s unique design (104-week registrational Phase 3 study; NCT01639339) investigating kidney outcomes with BEL allowed ISN/RPS class III or IV ± V or pure class V, …

us, de, gr (code pays fourni par la source)

Altered NPTX2 dynamics associated with impaired cognitive aging

Rebecca P. Haberman, Ana R. Delgado, Mei-Fang Xiao, Ming Teng Koh et autres

Abstract Changes in synaptic integrity and neural activity homeostasis are hallmarks of brain aging and are closely tied to cognitive outcomes. Yet, defining their relationship across the continuum from normal aging to neurodegenerative disease has proven challenging. Recent research investigating the dynamic …

us (code pays fourni par la source)

COMPLETE RENAL RESPONSES AND SAFETY FOR BELIMUMAB VERSUS PLACEBO IN A POST HOC MYCOPHENOLATE MOFETIL SUBGROUP WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS

Richard Alan Furie, Hans‐Joachim Anders, George Βertsias, Ana R. Delgado et autres

O056a/ #846 Topic:AS15 - Lupus Nephritis-Clinical Late-Breaking Abstract ABSTRACT CONCURRENT SESSION 09: SLE THERAPY – REVISITING OLD DRUGS AND UNLOCKING HIDDEN POTENTIAL OF NEW MEDICATIONS 24-05-2025 10:40 AM - 11:40 AM Background/Purpose Belimumab, a human IgG1λ monoclonal antibody that selectively binds B …

us, de, gr, ie (code pays fourni par la source)

El Conocimiento de las Emociones en las Mujeres Paraguayas Víctimas de Violencia

Reinhardt Fischer, Gerardo Prieto, Ana R. Delgado

As part of the validation process of an emotion knowledge test based on the Theory of Conceptual Act, and composed of three subtests, the performance of a sample of Paraguayan women victims of violence (n = 43) and a comparison group (n …

es (code pays fourni par la source)

Validating the Short Emotional Vocabulary Test for Adolescents (SEVTA)

Alejandra Daniela Calero, Ana R. Delgado, Débora Inés Burín

ar, es (code pays fourni par la source)

Short Emotional Vocabulary Test for Adolescents

Alejandra Daniela Calero, Ana R. Delgado, Débora Inés Burín

Perspectives of Certified Nurse‐Midwives and Physicians on the Structural and Institutional Barriers that Contribute to the Reproductive Inequities of Black Birthing People in the San Francisco Bay Area

T. Nelson, Brittany D. Chambers, Ana R. Delgado, Monica R. McLemore

INTRODUCTION: Black birthing people in the United States disproportionately endure inequitable experiences and outcomes during pregnancy and childbirth via structural, interpersonal, and obstetric racism. In this study, the researchers explore provider perspectives of how racism is perpetuated in institutional perinatal and reproductive …

us (code pays fourni par la source)

#4516 CLINICAL CHARACTERISTICS OF PATIENTS WITH LUPUS NEPHRITIS CLASS III–V: ANALYSIS OF INTERNATIONAL REAL-WORLD DATA

Seth Anderson, Ana R. Delgado, Xin He, Zhiliu Tang et autres

Abstract Background and Aims Lupus nephritis (LN) is a severe renal manifestation of systemic lupus erythematosus (SLE) that negatively impacts morbidity and mortality; however, real-world data for LN is scarce. This study describes: the proportion of patients with SLE managed by rheumatologists …

cn, gb (code pays fourni par la source)

Complex Syntax Methods of Assessment: Relative Clauses

Ana R. Delgado

Relative clauses are a type of complex syntax in which a clause modifies a noun (e.g., “the dog that runs in the house”). Some children struggle to produce relative clauses and their difficulties may impact their academic performance. Assessments that measure children’s …

us (code pays fourni par la source)